A device in clinical development appears to be far safer and more effective than the TAVI devices currently being used ...

A new study published in The New England Journal of Medicine showed that stroke was not prevented by routinely using devices ...

With surveillance, conversion to acute valve syndrome happened frequently and was linked to worse clinical outcomes.

The “passive” notification led to more patients with severe AS undergoing valve replacement, but more can be done still.

The DapaTAVI trial assessed the benefits of dapagliflozin in patients discharged after TAVI with a history of heart failure plus 1 of the following comorbidities: LVEF ≤40%, diabetes, or renal ...

BACKGROUND: Real-world low-risk transcatheter aortic valve replacement (TAVR) outcomes in the United States have not been assessed comprehensively versus pivotal trials, which is a key component of ...

Patients with severe aortic stenosis at low surgical risk who underwent supra-annular, self-expanding Evolut transcatheter ...

Researchers found that at five years, patients with severe aortic stenosis who were treated with either TAVR or surgery had comparable rates of all-cause mortality or disabling stroke.

Olive Hospital has achieved a major breakthrough in the field of Interventional Cardiology by successfully completing its ...

A new method of alerting clinical care providers holds promise for increasing treatment and improving survival for patients with severe aortic ...

Here are the biggest stories out of ACC 2025: Five-year data from the Medtronic Evolut Low Risk Trial confirmed that its ...

Aortic valve stenosis' is an often-overlooked condition and a growing health concern in ageing societies such as Thailand. With an increasing elderly population and a rise in age-related valve ...